V

Verrica Pharmaceuticals
D

VRCA

6.75500
USD
1.72
(34.03%)
قبل الجلسة
حجم التداول
4
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
64,105,186
الأخبار المقالات

العنوان: Verrica Pharmaceuticals Inc

القطاع: Healthcare
الصناعة: Biotechnology
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.